The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

Start with the patient’s chief complaint when making a differential diagnosis in uveitis, a retina specialist said at Retina ...

The iDose platform is designed to address ubiquitous patient non-adherence and chronic side effects associated with topical medications by providing 24/7 release of medication.

Continuous Glucose Monitor Data Predicts Type 1 Diabetes Complications Jan. 15, 2025 — Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes ...